Verona Pharma plc (VRP.L) (LON:VRP) Stock Crosses Above 200 Day Moving Average – Here’s What Happened

Verona Pharma plc (VRP.L) (LON:VRP) shares passed above its 200-day moving average during trading on Wednesday . The stock has a 200-day moving average of GBX 55 ($0.72) and traded as high as GBX 56 ($0.73). Verona Pharma plc (VRP.L) shares last traded at GBX 55 ($0.72), with a volume of 70,791 shares.

Verona Pharma plc (VRP.L) Stock Up 5.8 %

The stock’s 50 day simple moving average is GBX 55 and its two-hundred day simple moving average is GBX 55. The firm has a market cap of £228.00 million and a P/E ratio of -1.68. The company has a debt-to-equity ratio of 6.85, a current ratio of 2.99 and a quick ratio of 2.47.

About Verona Pharma plc (VRP.L)

Verona Pharma plc, a clinical stage biopharmaceutical company, develops and commercializes therapeutics to treat respiratory diseases. The company's product candidate is RPL554, an inhaled dual inhibitor of the enzymes phosphodiesterase 3 and 4, which has completed Phase I and II clinical trials that acts as a bronchodilator and an anti-inflammatory agent for the treatment of chronic obstructive pulmonary disease, cystic fibrosis, chronic asthma, and allergic rhinitis.